Chemistry World: More Than a Mirror-Image: Left-Handed Nucleic Acids

Two double helixes of DNA, one appears normal and the other appears jagged and damaged.
February 20, 2024
The Division of Pharmacology & Toxicology's Karen Vasquez, Ph.D. talked to Chemistry World's Rachel Brazil on genetic instability in disease and evolution of course related to Z-DNA. Dr. Vasquez's research focuses on genome instability, DNA damage and mechanisms of repair.

Texas Pharmacy Again Wins Insight Into Diversity HEED Award

INSIGHT Into Diversity Higher Education Excellence in Diversity Award, 2023. Health Professions School.
October 11, 2023
The University of Texas at Austin College of Pharmacy received the 2023 Health Professions Higher Education Excellence in Diversity (HEED) Award from INSIGHT Into Diversity magazine, the oldest and largest diversity-focused publication in higher education. This is the second year Texas Pharmacy has been named as a Health Professions HEED Award recipient and is one of six pharmacy schools in the nation to receive the award.

Graduate Student First Author on PNAS Paper

Three people standing in front of a research poster. One person is giving the Hook 'em Horns hand gesture.
June 13, 2023
Kimberly J. Long, a Ph.D. candidate in the Dalby Lab in the Division of Chemical Biology and Medicinal Chemistry, was a first author of a recent research paper published in the Proceedings of the National Academy of Sciences (PNAS).

Texas Pharmacy Earns NACDS Grant

Four people giving the Hook 'em Horns hand gesture and holding a framed certificate.
April 27, 2023
The National Association of Chain Drug Stores (NACDS) Foundation awarded The University of Texas at Austin College of Pharmacy Office of Opportunity and Belonging with a $15,000 Diversity Scholarship Award to expand the college's Project Engage Pharmacy Program (PEPP).

Bold Pursuits in Health and Well-Being

Body and Soul: Bold pursuits in health and the arts. Includes an image of a large copper shell sculpture.
March 20, 2023
College of Pharmacy Dean Sam Poloyac participated in a panel discussion from the 2023 Texas Leadership Society Luncheon on The University of Texas at Austin's bold pursuits in health and well-being. The discussion was moderated by UT President Jay Hartzell.

Texas Pharmacy Welcomes New Assistant Dean for Diversity and Inclusion

A woman smiling while wearing a blazer.
January 18, 2023
Texas Pharmacy is delighted to announce its new Assistant Dean for Diversity and Inclusion Tonia Guida, Ph.D.

Vasquez Writes in Nature Reviews Genetics on Alternative DNA Structures

"Nature Reviews Genetics" written inside of a circle.
November 1, 2022
Division Head and Professor of Pharmacology & Toxicology Karen Vasquez, Ph.D. published in the latest issues of Nature Reviews Genetics regarding repetitive elements in the human genome. Once considered "junk DNA," they are now known to adopt more than a dozen alternative DNA structures. These dynamic conformations can act as functional genomic elements involved in DNA replication and transcription, chromatin organization and genome stability.

Faculty Earn State Grants for Cancer Research

A person in a lab.
September 21, 2022
The Cancer Prevention and Research Institute of Texas (CPRIT) has released its grant research funding awards for the upcoming year. All three awarded research projects at The University of Texas at Austin involve College of Pharmacy faculty.

Dalby Earns CPRIT Grant for Drug Delivery Program

A person wearing a mask in a lab.
September 16, 2021
The Cancer Prevention and Research Institute of Texas (CPRIT) recently awarded grants to six faculty members at UT Austin, including the Division of Chemical Biology and Medicinal Chemistry's Kevin Dalby, Ph.D. for his Targeted Therapeutic Drug Discovery and Development Program.

Vasquez Appears on BBC World Service to Discuss Z-DNA

DNA.
June 16, 2021
Division Head and Professor of Pharmacology and Toxicology Karen Vasquez, Ph.D. appeared on BBC World Service's Science in Action to talk about Z-DNA. Dr. Vasquez's research focuses on DNA damage and repair, genomic instability, gene targeting, DNA structure and cancer therapeutics.